Purchase of 1,500 shares at 1265
Oryx International Growth Fund Ld
30 July 2026
30 July 2026
Oryx International Growth Fund Limited
(the "Company")
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
On 21 July 2026, Mr Harry Mills, a Person Closely Associated with Mr Christopher Mills (Director of the Company), purchased a further 1,500 shares in the Company.
The below notification, made in accordance with the requirements of article 19.3 of the UK Market Abuse Regulation, gives further details:
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
1) Christopher Mills 2) Harry Mills |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
1) Director 2) PCA |
||||
|
b)
|
Initial notification /Amendment |
Initial Notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Oryx International Growth Fund Limited |
||||
|
b)
|
LEI |
213800W5W6THP34TW941 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares SEDOL : B3BTVQ9 |
||||
|
b)
|
Nature of the transaction |
Purchase |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Aggregated volume - Price per share |
1,500 £12.65 |
||||
|
e) |
Date of the transaction |
21 July 2026 |
||||
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.